Cary N. Robertson

Race is associated with discontinuation of active surveillance of low-risk prostate cancer: Results from the Duke Prostate Center

Michael N. Ferrandino, J. Moul, S. Freedland, 2012, Prostate Cancer and Prostatic Diseases.

Adjuvant radiotherapy for pathologic stage T3/4 adenocarcinoma of the prostate: ten-year update.

M. Anscher, L. Prosnitz, C. Robertson, 1995, International journal of radiation oncology, biology, physics.

Patient selection for prostate focal therapy in the era of active surveillance: an International Delphi Consensus Project

J. Coleman, H. Ahmed, L. Klotz, 2017, Prostate Cancer and Prostatic Diseases.

Follow-up modalities in focal therapy for prostate cancer: results from a Delphi consensus project

J. Fütterer, P. Pinto, T. Reijke, 2015, World Journal of Urology.

Clinical Investigation : Genitourinary Cancer The Number of High-Risk Factors and the Risk of Prostate Cancer e Specific Mortality After Brachytherapy : Implications for Treatment Selection

A. D'Amico, Ming-Hui Chen, J. Moul, 2012 .

The role of magnetic resonance imaging (MRI) in focal therapy for The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel prostate cancer: recommendations from a consensus panel

J. Fütterer, J. Kurhanewicz, J. Moul, 2022 .